Literature DB >> 11536403

MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver.

T R Bader1, R C Semelka, V C Chiu, D M Armao, J T Woosley.   

Abstract

The purpose of this study was to evaluate the spectrum of appearances of gastrointestinal carcinoid tumors at magnetic resonance imaging (MRI) and to elucidate patterns of appearances of carcinoid liver metastases on precontrast and postgadolinium images. The MR examinations of 29 patients (11 men, 18 women; age range, 33-87 years) with histologically confirmed gastrointestinal carcinoid tumors, representing our complete 9.5 years of experience with this entity, were retrospectively reviewed. Twelve patients had MR examinations prior to resection or biopsy of the primary tumor (preoperative group); 17 patients were imaged postsurgically (postoperative group). All MR studies were performed at 1.5 T and comprised T1-weighted spoiled gradient echo (SGE), T2-weighted fat-suppressed turbo spin echo, HASTE, and serial postgadolinium T1-weighted SGE sequences without and with fat suppression. Morphology, signal intensity, and contrast enhancement of primary tumors and of metastases to the mesentery, peritoneum, and liver were evaluated. Primary tumors were visualized in 8 of 12 patients and best demonstrated on postgadolinium T1-weighted fat-suppressed images. The appearance of primary tumors was a nodular mass originating from the bowel wall (4 of 12 patients) or regional uniform bowel wall thickening (4 of 12 patients) with moderate intense enhancement on postgadolinium images. In 4 of 12 patients the primary tumor was prospectively not seen. Mesenteric metastases, seen in eight patients, presented as nodular masses and were associated with mesenteric stranding in seven patients. A total of 156 liver metastases were evaluated in 16 patients. On precontrast T1- and T2-weighted images, 117 metastases (75%) were hypointense and hyperintense, respectively. A total of 146 metastases (94%) were hypervascular, showing moderate intense enhancement during the hepatic arterial phase, and 9 metastases (6%) were hypovascular. Twenty-three metastases (15%) were visible only on immediate postgadolinium images. MRI is able to demonstrate findings in carcinoid tumors, including the primary tumor, mesenteric metastases, and liver metastases. Liver metastases are commonly hypervascular and may be demonstrable only on immediate postgadolinium images. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11536403     DOI: 10.1002/jmri.1182

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  33 in total

1.  New progress in CT and MRI examination and diagnosis of small intestinal tumors.

Authors:  Fei Miao; Ming-Liang Wang; Yong-Hua Tang
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

2.  Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease.

Authors:  Stefan K Gölder; Andreas G Schreyer; Esther Endlicher; Stefan Feuerbach; Jürgen Schölmerich; Frank Kullmann; Johannes Seitz; Gerhard Rogler; Hans Herfarth
Journal:  Int J Colorectal Dis       Date:  2005-04-22       Impact factor: 2.571

3.  CT and MR features of sclerosing mesenteritis mimicking a mesenteric metastasis from the carcinoid tumor.

Authors:  Mitsuru Matsuki; Yuki Inada; Go Nakai; Fuminari Tatsugami; Masato Tanikake; Isamu Narabayashi; Haruto Nishimura; Mitsuhiko Iwamoto; Masako Hiramatsu; Nobuhiko Tanigawa; Yoshitaka Kurisu; Motomu Tsuji
Journal:  Radiat Med       Date:  2006-04

Review 4.  Endoscopic techniques to detect small-bowel neuroendocrine tumors: A literature review.

Authors:  Roberta Elisa Rossi; Dario Conte; Luca Elli; Federica Branchi; Sara Massironi
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

Review 5.  Recent advances in the imaging of adrenal and neuroendocrine tumours.

Authors:  Priya Narayanan; Rodney Reznek
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

6.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

7.  Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?

Authors:  Julia Neperud; Armeen Mahvash; Naveen Garg; Ravi Murthy; Janio Szklaruk
Journal:  World J Radiol       Date:  2013-06-28

8.  Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.

Authors:  Gustavo Felipe Luersen; W Wei; Eric P Tamm; Priya R Bhosale; Janio Szklaruk
Journal:  J Comput Assist Tomogr       Date:  2016 Sep-Oct       Impact factor: 1.826

9.  Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.

Authors:  Ashley Kieran Clift; Omar Faiz; Adil Al-Nahhas; Andreas Bockisch; Marc Olaf Liedke; Erik Schloericke; Harpreet Wasan; John Martin; Paul Ziprin; Krishna Moorthy; Andrea Frilling
Journal:  J Gastrointest Surg       Date:  2015-09-22       Impact factor: 3.452

Review 10.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.